Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Australian Floating Rate ETF (FLOT) vs Eli Lilly And Co (LLY) Price & Performance

VanEck Australian Floating Rate ETFTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

VanEck Australian Floating Rate ETF vs Eli Lilly And Co — how do they compare? VanEck Australian Floating Rate ETF trades at $50.98, while Eli Lilly And Co trades at $1,186.83 (market cap $1.03T). The key difference: Eli Lilly And Co pays a 0.6% dividend while VanEck Australian Floating Rate ETF pays none. Which is the better fit depends on your goals.

FLOTLLY
Sector
Sector/ThematicHealth
52-Week High
$51.09$1.24K
52-Week Low
$50.72$625.65
Market Cap
$1.03T
Enterprise Value
$1.07T
Dividend Yield
0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Australian Floating Rate ETF

No Aura AI signal available yet.

Eli Lilly And Co

LLY trades at $1,154.27, down 2.6% today, amid a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $8.55 surpassing the $6.97 forecast. Revenue surged to $65.18B in 2025, driving a net income margin of 34.99%. Recent news includes the acquisition of AtaiBeckley for $2.8 billion, expanding its neuroscience pipeline.

Outlook remains positive with a consensus price target of $1,380, though high valuation multiples (P/E 41.09) and competitive pressures in obesity drugs present risks. Analyst sentiment is strongly bullish (73% buy ratings), supporting further upside if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About VanEck Australian Floating Rate ETF

FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.

Read more on FLOT

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY